tbuckley/cabot-search huggingface dataset:
Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR– EPOR Chimeras
Authors: Mor Gross, Nathalie Ben-Califa, Hans Carl Hasselbalch, Mary Frances McMullin, Melanie Percy, Celeste Bento, Holger Cario, Milen Minkov, Drorit Neumann
Journal: Blood (2013)
The Growth of Estrogen-Induced Interstitial-Cell Testicular Tumors in BALB/c Mice
Authors: Howard B. Andervont, Michael B. Shimkin, Harry Y. Canter
Journal: JNCI Journal of the National Cancer Institute (1960)

Strain BALB/c male mice, 2 months old, were implanted with stilbestrol-cholesterol pellets, which were removed either when one or both testes became enlarged to 9 to 10 mm. in length, or 2 weeks later. The interstitial-cell tumors thus induced were measured weekly and the growth patterns analyzed. There were at least 7 separable growth patterns, which again could be combined into tumors that grew, persisted without continued growth, or regressed; a proportion of the latter recurred after variable periods. Bilateral tumors behaved as variably as unilateral tumors. Mice exposed to estrogen 2 weeks longer after the appearance of a tumor had more tumors that grew progressively and fewer that regressed than mice whose pellets were removed as soon as they developed tumors. Exposure of mice to testosterone or to progesterone did not affect the rate of recurrence of tumors that had regressed. The variability of growth patterns indicates no single evolutionary progression for the tumors but a great number of general and local factors in what biologically must be an unstable system between tumor and host.
Abstract 22: Systemic Nitrite (NO2-) Levels are Depleted in a Mouse Model of Asystolic Cardiac Arrest and Therapeutic Repletion Improves Survival and Functional Neurological Recovery
Authors: Cameron Dezfulian, Aleksey Alekseyenko, Kenneth R Jeffries, Mark T Gladwin
Journal: Circulation (2007)

Nitrite (NO2) represents a circulating reservoir of nitric oxide (NO) that is reduced to NO during ischemia. In pre-clinical studies, NO2 therapy was cytoprotective following focal heart, brain and liver ischemia-reperfusion. We hypothesized that systemic NO2 is depleted during global ischemia (cardiac arrest) and its early repletion could protect the heart and brain from reperfusion injury. C57BL/6 mice were rendered asystolic using a KCl bolus. After 12 min of warm ischemia (36.5C), paired mice were randomized to IV nitrite (blinded) or saline placebo given just prior to epinephrine, mechanical ventilation and chest compressions. All mice received identical pre- and post-CPR care until euthanasia and had similar physiologic parameters. NO2-treated mice had improved survival 22 hours post-CPR compared to saline-treated controls (HR 2.75 [95% CI:1.1– 6.8]; Table 1 ). Deaths occurred 1– 6 h post-CPR and were associated with worsened cardiac ejection fraction 1.5h post-CPR. Neurologic function and thermoregulation were significantly improved in NO2-treated 22h survivors vs. paired controls. Cardiac arrest depleted whole blood and plasma NO2 (Table 2 ). NO2 therapy restored levels near pre-arrest baseline with associated improvements in post-CPR oxygenation, ventilation and pH, without altering metabolic acidosis. Intravenous NO2 as adjunctive therapy to epinephrine early in CPR shows promise in improving cardiac and neurologic outcomes in a mouse model of cardiac arrest. The ease of NO2 delivery (vs. hypothermia), its approval and known safety profile in humans and its efficacy against reperfusion injury after prolonged asystole make NO2 an excellent drug candidate. Survival, Cardiac and Neurologic Function After Resuscitation from Cardiac Arrest Arterial Nitrite Levels and Blood Gases 5 minutes After Resuscitation from Cardiac Arrest
Abstract 3508: Integrin Linked Kinase (ILK) is Cardioprotective Against Ischemia
Authors: Mark Walsh, Xiaojing Dai, Alex Traister, Yuqing Zhou, A Momen, Mingliang Lu, Greg E Hannigan, John G Coles
Journal: Circulation (2009)

Introduction: Integrin linked kinase (ILK) is a multifunctional protein kinase which regulates a wide variety of cellular functions such as hypertrophy, angiogenesis, migration, proliferation, moti...
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
Authors: David J. Katzelnick, Kenneth A. Kobak, John H. Greist, James W. Jefferson, Julia M. Mantle, Ronald C. Serlin
Journal: American Journal of Psychiatry (1995)

The authors examined the efficacy of sertraline in the treatment of social phobia.In a double-blind crossover study, 12 outpatients were randomly assigned to 10 weeks of sertraline (50-200 mg/day, flexible dosing) and 10 weeks of placebo.A statistically significant improvement in scores on the Liebowitz Social Anxiety Scale was found with sertraline but not with placebo. There was no significant difference between scores obtained with computer- and clinician-administered versions of the Liebowitz Social Anxiety Scale, and the majority of patients preferred to be interviewed by the computer.Sertraline seems a safe and effective treatment for social phobia, and computer administration may be a preferable mode of assessment with socially phobic patients.
Abstract 3668: Predictors of Four-Year Incident Arterial Hypertension From Initial Prehypertension: The Strong Heart Study.
Authors: Marina De Marco, Marcello Chinali, Mary J. Roman, Elisa T. Lee, Marie Russell, Barbara V. Howard, Giovanni de Simone, Richard B. Devereux
Journal: Circulation (2007)

Background: Pre-hypertension (defined by JNC-VII) frequently evolves to arterial hypertension (HTN) and is recently shown to increase cardiovascular risk, especially in diabetics. It is unclear which metabolic and cardiac characteristics predict development of HTN in pre-hypertensive subjects. Methods: 627 pre-hypertensive participants in the Strong Heart Study, free of anti-hypertensive treatment and without prevalent cardiovascular disease or significant valve disease, were studied (64% women; 41% diabetic; 58±7 yrs). All participants underwent complete echocardiographic, anthropometric and laboratory testing. We evaluated 4-year incidence of HTN using anthropometric and metabolic profile as first predictors, and echocardiographic indices thereafter. Results: Four-year incidence of HTN was 41%. Preliminary analysis identified diabetes (DM by ADA criteria) as a significant predictor of incident HTN (53% among participants with DM vs 33% in non DM; OR= 2.02, 95% CI=1.42–2.88; p&lt;0.001). Accordingly, additional analysis was performed separately in participants with or without baseline DM. After adjusting for age, gender, and heart rate, strongest predictor of HTN in DM was baseline systolic blood pressure (OR= 1.07/mmHg, 95% CI=1.03–1.12; p=0.001) with weaker effect of echocardiographic relative wall thickness (p=0.03). In non-DM, independent predictors of HTN were systolic blood pressure (HR= 1.08/mmHg, 95% CI=1.04–1.12; p&lt;0.001), non-HDL cholesterol (HR= 1.01/mg*dL-1, 95% CI=1.00–1.01; p=0.01) and high LV mass index (OR=1.04 g/m2.7, 95% CI=1.01–1.07; p= 0.007). Higher Doppler stroke volume and total peripheral resistance also entered alternative models without LV mass (each p&lt;0.05). Conclusion: In a population of pre-hypertension adults we demonstrate high incidence of HTN (41%). Independent predictors of HTN at 4-year follow-up are presence of diabetes and higher baseline systolic blood pressure. In non-DM, LV mass index is an indipendent predictor of incident HTN in addition to baseline systolic blood pressure and non-HDL cholesterol.
Highlights of the 18th Annual Scientific Sessions of the American Society of Echocardiography
Authors: Roberto M. Lang, Patrick D. Coon, Julius M. Gardin, Kirk T. Spencer, Theresa A. Tacy, Mani A. Vannan, Neil J. Weissman, William A. Zoghbi, Michael H. Picard
Journal: Journal of the American College of Cardiology (2007)
512. Intra-Amniotic Application of CFTR-Expressing Adenovirus Does Not Reverse Cystic Fibrosis Phenotype in Inbred Cftr-Knockout Mice
Authors: Smk Buckley, SN Waddington, S Jezzard, M Themis, WH Colledge, C Coutelle
Journal: Molecular Therapy (2003)
Maintenance Dosage of Liver Extract in the Treatment of Pernicious Anemia
Authors: Paul J. Fouts, L. G. Zerfas
Journal: Annals of Internal Medicine (1933)

Article1 April 1933Maintenance Dosage of Liver Extract in the Treatment of Pernicious AnemiaPAUL J. FOUTS, M.D., L. G. ZERFAS, M.D.PAUL J. FOUTS, M.D.Search for more papers by this author, L. G. ZERFAS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-6-10-1298 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn presenting data relative to the maintenance dosage of liver extract or other substances potent in the treatment of pernicious anemia, it is necessary to define and state the requirements which this term implies. Beebe and Lewis1have clearly defined these requirements in a recent report of a large series of cases observed at the Thorndike Memorial Laboratory and at the Boston City Hospital. They stated that, "although the level of the red blood cells and hemoglobin serves as one important guide to the amount of therapeutic material necessary for the maintenance of health, there are other aspects of each...Bibliography1 BEEBELEWIS RTGE: The maintenance dose of potent material in pernicious anemia, Am. Jr. Med. Sci., 1931, clxxxi, 796-812. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Indianapolis, Indiana*Received for publication March 5, 1932.†From the Lilly Laboratory for Clinical Research, Indianapolis City Hospital, and the Department of Medicine, Indiana University School of Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byABSORPTION OF RADIOACTIVE B12 IN PATIENTS WITH PERNICIOUS ANEMIA AFTER LONG-TERM ORAL AND PARENTERAL THERAPY*P. J. FOUTS, M.D., F.A.C.P., O. M. HELMER, Ph.D., S. M. CHERNISH, M.D.Die Erkrankungen des erythrocytären Systems 1 April 1933Volume 6, Issue 10Page: 1298-1304KeywordsClinical laboratoriesHemoglobinHospital medicineLiverPernicious anemiaRed blood cellsResearch laboratories ePublished: 1 December 2008 Issue Published: 1 April 1933 PDF downloadLoading ...
Carfilzomib, a Second-Generation Proteasome Inhibitor, In Combination With The Btk Inhibitor Ibrutinib As a Novel Therapeutic Regimen For Treating Double Hit DLBCL
Authors: Erin M Dominici, Elyse R Lopez, Muychi T Vang, Archito T. Tamayo, Zhishuo Ou, Alex Rollo, Liang Zhang, Jack Wang, Lauren M Strickland, Michael Wang, Richard J. Ford, Lan V Pham, Christopher J. Kirk
Journal: Blood (2013)
THE ARMY'S NEW FRONTIERS IN TROPICAL MEDICINE
Authors: James Stevens Simmons
Journal: Annals of Internal Medicine (1942)

Article1 December 1942THE ARMY'S NEW FRONTIERS IN TROPICAL MEDICINEJAMES STEVENS SIMMONS, M.D., F.A.C.P.JAMES STEVENS SIMMONS, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-17-6-979 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONThe United States Army is now engaged in an "all-out" war in the tropics. Since December 1941, American soldiers have been sent to new frontiers scattered throughout the tropical regions of the world. On these frontiers, they face powerful enemy forces and an alarming array of tropical diseases. Certain of these diseases are potentially so disabling that unless controlled they will interfere with military efficiency; in fact it is conceivable that they might play a significant rôle in determining the final outcome of the war. The protection of our troops against such diseases is, therefore, of vital importance, and... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Medical Corps United States Army*Read at the St. Paul meeting of the American College of Physicians April 22, 1942.†Chief, Preventive Medicine Service, Office of The Surgeon General, United States Army. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byBrigadier General James Stevens Simmons (1890–1954), Medical Corps, United States Army: a career in preventive medicine 1 December 1942Volume 17, Issue 6Page: 979-988KeywordsArmed forcesPreventive medicineSurgeonsTropical diseases Issue Published: 1 December 1942 PDF downloadLoading ...
Management of Community-Acquired Pneumonia
Authors: Ethan A. Halm, Alvin S. Teirstein
Journal: New England Journal of Medicine (2002)

A 65-year old man with hypertension and degenerative joint disease presents to the emergency department with a three-day history of a productive cough and fever. His temperature is 38.3°C (101°F), his blood pressure is 144/92 mm Hg, his respiratory rate is 22 breaths per minute, his heart rate is 90 beats per minute, and his oxygen saturation is 92 percent while he is breathing room air. Physical examination reveals only crackles and egophony in the right lower lung field. The white-cell count is 14,000 per cubic millimeter, and routine chemical tests are normal. A chest radiograph shows an infiltrate in the right lower lobe. How should this patient be treated?
Reply
Authors: Giulio Conte, Juan Sieira, Giuseppe Ciconte, Carlo de Asmundis, Gian-Battista Chierchia, Giannis Baltogiannis, Giacomo Di Giovanni, Mark La Meir, Francis Wellens, Jens Czapla, Kristel Wauters, Moises Levinstein, Yukio Saitoh, Ghazala Irfan, Justo Julià, Gudrun Pappaert, Pedro Brugada
Journal: Journal of the American College of Cardiology (2015)
Correspondence
Authors: Henry L Shively
Journal: JAMA (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diagnosis of Protozoa and Worms Parasitic in Man.
Authors: Robert William Hegner, William Walter Cort
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 714: Left Atrial Enlargement in 515 Either Endurance or Strength Competitive Athletes
Authors: Antonello D'Andrea, Pio Caso, Olga Vriz, Rodolfo Citro, Rita Gravino, Rosangela Cocchia, Lucia Riegler, Raffaele Calabro, Edoardo Bossone
Journal: Circulation (2009)
REGIONAL ENTERITIS: AN EVALUATION OF THE PRESENT-DAY THERAPEUTIC MANAGEMENT
Authors: J A BARGEN
Journal: Annals of Internal Medicine (1957)

Article1 November 1957REGIONAL ENTERITIS: AN EVALUATION OF THE PRESENT-DAY THERAPEUTIC MANAGEMENTJ. ARNOLD BARGEN, M.D., F.A.C.P.J. ARNOLD BARGEN, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-47-5-875 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONMuch has been said and written about regional enteritis in the last few years. On the basis of description, it is a comparatively new entity, for an accurate characterization of it did not exist until Crohn and his associates defined it decisively in 1932. Thus, from a period early in our century up to the present, there have been an impressive accumulation of information about regional enteritis and an extensive collection of data concerning patients with the disease. One of the problems remaining is adequate evaluation of our information to date.Regional enteritis attacks mainly young adult persons. It... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Rochester, Minnesota*Presented at the Thirty-eighth Annual Session of The American College of Physicians, Boston, Massachusetts, April 11, 1957.From the Section of Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.The Mayo Foundation, Rochester, Minnesota, is a part of the Graduate School of the University of Minnesota.Requests for reprints should be addressed to Section of Publications, Mayo Clinic, Rochester, Minnesota. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPharmacotherapy of inflammatory bowel diseaseSalicylazosulfapyridine in inflammatory bowel diseaseMedical TreatmentClinical and radiologic improvement of regional enteritis and enterocolitis after treatment with salicylazosulfapyridineThe clinical course of regional ileitis 1 November 1957Volume 47, Issue 5Page: 875-879KeywordsAnemiaDiarrheaEmotionsEnteritisFistulasGraduate medical educationYoung adults ePublished: 1 December 2008 Issue Published: 1 November 1957 PDF downloadLoading ...
Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model
Authors: Oleg V. Markov, Nadezhda L. Mironova, Elena V. Shmendel, Roman N. Serikov, Nina G. Morozova, Mikhail A. Maslov, Valentin V. Vlassov, Marina A. Zenkova
Journal: Journal of Controlled Release (2015)
Abstract 14966: Age Related Macular Degeneration and Coronary Artery Disease: Evidence of an Association in the US Veterans Population
Authors: Joseph E Thomas, Sohail I Mohammad, Ahmed Abdel-Latif, Richard Charnigo, Judit Baffi, Khaled M Ziada
Journal: Circulation (2011)

Objective: Age related macular degeneration (AMD) is the leading cause of blindness in the United States. Although AMD shares multiple risk factors with coronary artery disease (CAD), the associati...
Why the analyses of cognitive processes matter
Authors: Ulrich Hoffrage
Journal: Behavioral and Brain Sciences (2000)

Stanovich &amp; West analyze individual differences with respect to response output (e.g., participants' numerical estimates). They do not analyze the underlying cognitive processes that led to the outputs; they thereby probably misclassify some non-normative responses as normative. Using base rate neglect and overconfidence as examples, I demonstrate the advantages of analyzing cognitive processes further.
Abstract 13338: A Molecular Signature with the Potential for Identifying Impending Acute Myocardial Infarction
Authors: Evan D Muse, Haiying Wang, Paddy Barrett, Fereshteh Parviz, Mark A Novotny, Roger S Lasken, Timothy A Jatkoe, Mark C Connelly, Kurt M Schilling, Chandra Rao, Ali Torkamani, Eric J Topol
Journal: Circulation (2014)

The inability to temporally and accurately predict acute myocardial infarction (AMI) impairs our ability to further improve patient outcomes. Prior work investigating the potential of circulating endothelial cells (CECs) as a biomarker for AMI has focused mainly on increased enumeration in AMI. Here we describe the designation of a specific gene expression pattern acting as a molecular signature for AMI present in whole blood of patients that was determined using microarray analysis of enriched CECs. Using CELLSEARCH® technology we first separated and enriched CECs from the peripheral blood of patients with AMI (n=53) or from healthy controls (n=53). Total RNA was analyzed using the Affymetrix Human U133 Plus 2.0 Microarray for the expression of over 47,000 transcripts. The expression profiles were examined to determine which genes were selectively up-regulated in AMI compared to controls. We nominated 19 candidate genes from the microarray analysis that demonstrated the ability to discriminate between AM...
The Hemopoietic Effect of Nuclear Extractives in Human Anemias
Authors: N. W. Jones, B. I. Phillips, Olof Larsell, H. T. Nokes
Journal: Annals of Internal Medicine (1929)

Article1 January 1929The Hemopoietic Effect of Nuclear Extractives in Human AnemiasN. W. JONES, M.D., B. I. PHILLIPS, M.D., OLOF LARSELL, Ph.D., H. T. NOKES, M.D.N. W. JONES, M.D.Search for more papers by this author, B. I. PHILLIPS, M.D.Search for more papers by this author, OLOF LARSELL, Ph.D.Search for more papers by this author, H. T. NOKES, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-2-7-603 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptWith no more than passing reference (1, 2, 3, 4) to the experimental work upon which the following clinical studies have been founded, we wish in this paper to relate briefly observations we have made on the effect of nuclear extractives in the treatment of anemia in human patients. The nuclear extractives used, as reported elsewhere, have been obtained by the methods of Hammarsten and of Kossel-Neumann from various organ sources, and have been considered to be nucleo-proteins and the sodium salts of nucleic acids. An unknown hemopoietic stimulant exists in both of these nuclear extractives, and because from both...References(1) Arch. Path. & Lab. Med, 1926, ii:698-703. Google Scholar(2) J. A. M. A., 1927, lxxxix :682-685. Google Scholar(3) J. A. M. A., 1928, xc:75-78. Google Scholar(4) Proc. Soc. Exp. Biol. & Med., 1928, xxv:No. 9. Google Scholar(5) Cited and reported: J. A. M. A., 1928, xc:75-78. Google Scholar(6) Proc. Soc. Exp. Biol. & Med., 1928, xxv:255. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Portland, Oregon Departments of Anatomy and Medicine University of Oregon Medical School*Aided by grant No. 128 from the Committee on Medical Research of the American Medical Association. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byChemistry of Anti-Pernicious Anemia Substances of LiverPhysiologie und Pathologie des AntiperniciosaprinzipsDas Wirksame Prinzip der Leber bei PerniziÖser Anämie 1 January 1929Volume 2, Issue 7Page: 603-621KeywordsAnemiaNucleic acidsSaltsSodium ePublished: 1 December 2008 Issue Published: 1 January 1929 PDF downloadLoading ...